Articles

Find an Article

Filter articles

Applied Filters

Showing 301 to 310 of 314 results

A new framework: challenging patents in changing times

01-01-2012Eldora Ellison and Eric Steffe

The America Invents Act was signed into law in September 2011, and many biotech companies are still trying to make sense of the new legislation. Eldora Ellison and Eric Steffe consider one of the most important changes.

Is there life for medical diagnostic patents after Prometheus?

01-01-2012MaryAnne Armstrong

The Supreme Court’s much-anticipated Prometheus decision has prompted strong reactions among IP practitioners, as MaryAnne Armstrong, PhD, explains.

Covering all the bases: An interview with BIO President Jim Greenwood

01-05-2011

BIO represents a broad constituency of biotechnology and life sciences companies. LSIPR talks to BIO president and CEO Jim Greenwood about patent reform, healthcare, court cases and plans for the future.

For better, for worse? How shifting IP laws change the global life sciences regulatory chessboard

01-05-2011

With IP laws around the world subject to frequent and sometimes unpredictable changes, it can be difficult to keep abreast of everything you need to know. Richard Gough and Jane Woodhouse take a look.

Building operative partnerships with law enforcement

01-05-2011Vaughn Volpi

There is a perfect storm brewing in the healthcare industry. Over the past few years, there has been an unprecedented rise in the trade of illicit healthcare products in the secondary market.

Clinical trials in BioPharma

US01-05-2011Eric Steffe

A recent study revealed that biotechnology companies or universities discovered 42 percent of all innovative drugs approved by the US Food and Drug Administration (FDA) between 1998 and 2007.

Clinical trials and stratified medicine—maximising patent exclusivity

01-05-2011Richard Korn and Stephanie Pilkington

The traditional business model for a new drug relies on a substantial period of market exclusivity to recoup extensive research and development costs.

US Patent Law changes appear imminent

US01-05-2011John Pegram and Mark Ellinger

US patent reform looks like it may finally be coming. John Pegram and Mark Ellinger explain the proposed changes.

Patenting genes and diagnostics

US01-05-2011Simon O’Brien and David Gass

As biotechnology patents continue to grow in importance, uncertainty remains on both sides of the Atlantic as to exactly what is patentable. Simon O’Brien and David Gass take a look.

Attacking the validity of selection patents

Canada01-05-2011Katie Wang

The Canadian Federal Court of Appeal recently considered whether ‘invalid selection’ can be an independent ground for invalidating selection patents. Katie Wang looks at the implications.

Showing 301 to 310 of 314 results

LSIPR